Prospective study of irrational prescription of teicoplanin in a large academic hospital: A dilemma of antimicrobial resistance
Objective: Teicoplanin is an antibiotic used to treat severe Gram-positive infections, especially those caused by methicillin-resistant Staphylococcus aureus(MRSA). In this study, we aimed to evaluate the pattern of teicoplanin rational prescribing to identify the factors which affected rational uti...
Main Authors: | Masoud Hajialigol, Shadi Farsaei, Kiana Shirani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Research in Pharmacy Practice |
Subjects: | |
Online Access: | http://www.jrpp.net/article.asp?issn=2319-9644;year=2020;volume=9;issue=1;spage=50;epage=55;aulast=Hajialigol |
Similar Items
-
Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia
by: Jang Ho Lee, et al.
Published: (2022-07-01) -
In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
by: Xu Y, et al.
Published: (2021-12-01) -
Investigation of the Minimal Inhibitory Concentration Values of Vancomycin, Teicoplanin and Linezolid among MRSA Isolated from Inpatients by E-test Method
by: Tuğrul HOŞBUL, et al.
Published: (2012-06-01) -
Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
by: Sarah S. Alghanem, et al.
Published: (2023-11-01) -
Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017
by: Lin Huang, et al.
Published: (2019-05-01)